Eden Research (LON:EDEN) Shares Down 3.3% – What’s Next?

Eden Research plc (LON:EDEN) fell 3.3% during trading on Friday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). Approximately 450,985 shares traded hands during mid-day trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Performance

The firm has a market cap of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92. The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26. The stock has a 50 day moving average of GBX 3.88 and a 200 day moving average of GBX 3.95.

Insider Activity

In other Eden Research news, insider Alexander John Abrey bought 540,540 shares of the firm’s stock in a transaction on Tuesday, January 28th. The shares were purchased at an average price of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). Also, insider Lykele van der Broek bought 256,000 shares of the stock in a transaction on Thursday, February 6th. The shares were acquired at an average cost of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,937.46). Corporate insiders own 14.02% of the company’s stock.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.